Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis
Launched by BEIJING TIANTAN HOSPITAL · Jun 5, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with atherosclerotic carotid stenosis;
- • Those who signed informed consent and volunteered to participate in this study.
- Exclusion Criteria:
- • Patients with combined severe stenosis of intracranial arteries;
- • Patients with combined cardiogenic embolism, vasculitis, entrapment aneurysm and other related cerebral infarction;
- • Combination of tumors, rheumatic immune system diseases, hematologic diseases and other diseases that change blood metabolism and proteomic characteristics;
- • There are contraindications to magnetic resonance scanning and allergy to gadolinium contrast agent;
- • Inability to cooperate in completing the relevant examinations.
About Beijing Tiantan Hospital
Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yan Zhang, MD
Principal Investigator
Beijing Neurosurgical Institution
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported